Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations.
about
Chromatin reprogramming in breast cancer.Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets.Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancerIs ctDNA the Road Map to the Landscape of the Clonal Mutational Evolution in Drug Resistance? Lessons from the PALOMA-3 Study and Implications for Precision MedicineUnraveling the clinicopathological features driving the emergence of mutations in metastatic breast cancer
P2860
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Allele-Specific Chromatin Recr ...... of ESR1 Activating Mutations.
@en
Allele-Specific Chromatin Recr ...... of ESR1 Activating Mutations.
@nl
type
label
Allele-Specific Chromatin Recr ...... of ESR1 Activating Mutations.
@en
Allele-Specific Chromatin Recr ...... of ESR1 Activating Mutations.
@nl
prefLabel
Allele-Specific Chromatin Recr ...... of ESR1 Activating Mutations.
@en
Allele-Specific Chromatin Recr ...... of ESR1 Activating Mutations.
@nl
P2093
P2860
P1433
P1476
Allele-Specific Chromatin Recr ...... of ESR1 Activating Mutations.
@en
P2093
Agostina Nardone
Ariel Feiglin
Diane Melchers
Eric P Winer
Gilles Buchwalter
Henry Long
Johann S Bergholz
Kayley Abell-Hart
MacIntosh Cornwell
P2860
P304
173-186.e5
P356
10.1016/J.CCELL.2018.01.004
P577
2018-02-01T00:00:00Z